Pelaez Andres, Mitchell Patrick O, Shah Nimesh S, Force Seth D, Elon Lisa, Brown Lou Ann S, Guidot David M
Division of Pulmonary & Critical Care and the Florida Hospital Heart/Lung Transplant Programs (AP), Orlando, Florida; Division of Pulmonary, Allergy and Critical Care Medicine (POM, NSS, DMG), Emory University, Atlanta, Georgia; Atlanta Veterans Affairs Medical Center (POM, DMG), Decatur, Georgia; Division of Cardiothoracic Surgery (SDF), Emory University, Atlanta, Georgia; Department of Biostatistics and Bioinformatics (LE), Rollins School of Public Health, Emory University, Atlanta, Georgia; and Department of Pediatrics (LASB), Emory University, Atlanta, Georgia.
Am J Med Sci. 2015 Feb;349(2):117-23. doi: 10.1097/MAJ.0000000000000361.
Primary graft dysfunction (PGD) following lung transplantation is clinically similar to the acute respiratory distress syndrome. Because alcohol abuse independently increases the incidence of acute respiratory distress syndrome in at-risk individuals, we hypothesized that donor alcohol use is correlated with an increased risk of PGD. As a pilot study, we collected alcohol use histories using a validated instrument, the Alcohol Use Disorder Identification Test questionnaire, from 74 donors and correlated these with the development of PGD in corresponding recipients. Nineteen percent (14/74) of donors were classified as heavy alcohol users, as defined by the Alcohol Use Disorder Identification Test scores≥8. In the 1st 4 days post-transplantation, similar percentages of recipients developed grade 3 PGD on at least 1 day (heavy alcohol user=29% [4/14] versus lighter alcohol user=27% [16/60]); however, recipients receiving a lung from a heavy alcohol user were more likely to have multiple and consecutive days of grade 3 PGD, especially in the 1st 48 hours post-transplant. Both median length of stay in the intensive care unit and hospital were somewhat longer in the heavy alcohol user group (9 versus 7 days and 19.5 versus 17.5 days, respectively). If these preliminary findings are validated in a multi-center study, they would have important implications not only for our understanding of the pathophysiology of PGD but also for the development of novel treatments based on the evolving evidence from experimental and clinical studies on how alcohol abuse renders the lung susceptible to acute edematous injury.
肺移植后的原发性移植肺功能障碍(PGD)在临床上与急性呼吸窘迫综合征相似。由于酗酒会独立增加高危个体患急性呼吸窘迫综合征的几率,我们推测供体饮酒与PGD风险增加相关。作为一项初步研究,我们使用经过验证的工具——酒精使用障碍识别测试问卷,收集了74名供体的饮酒史,并将其与相应受者PGD的发生情况进行关联。根据酒精使用障碍识别测试得分≥8的标准,19%(14/74)的供体被归类为重度饮酒者。在移植后的前4天,相似比例的受者至少有1天出现3级PGD(重度饮酒者=29% [4/14],轻度饮酒者=27% [16/60]);然而,接受重度饮酒者供肺的受者更有可能出现多次且连续数天的3级PGD,尤其是在移植后的前48小时内。重度饮酒者组在重症监护病房和医院的中位住院时间均略长(分别为9天对7天和19.5天对17.5天)。如果这些初步研究结果在多中心研究中得到验证,它们不仅将对我们理解PGD的病理生理学具有重要意义,而且对于基于酗酒如何使肺易患急性水肿性损伤的实验和临床研究不断发展的证据开发新的治疗方法也具有重要意义。